REGN Free Cash Flow Growth
Regeneron Pharmaceuticals · Free Cash Flow Growth
REGN Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.39%period ending
REGN TTM Free Cash Flow YoY % (-96.32% → -8.39%)
Year-over-year change
High-resolution chart · PNG
REGN free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| -8.3936% | |
| 37.5848% | |
| 13.4354% | |
| 22.9956% | |
| 19.8329% | |
| -24.015% | |
| -5.667% | |
| -26.6505% | |
| -22.7456% | |
| 8.765% | |
| -13.8198% | |
| -9.2597% | |
| -47.2225% | |
| -53.9535% | |
| -32.2327% | |
| -5.6993% | |
| 364.6413% | |
| 291.1721% | |
| 225.8997% | |
| 240.0999% | |
| -30.1765% | |
| 18.9493% | |
| 0.155% | |
| -20.6986% | |
| 27.2241% | |
| -18.5988% | |
| 10.3974% | |
| 22.5614% | |
| 16.494% | |
| 65.1846% | |
| 75.1571% | |
| 102.8347% | |
| 67.0016% | |
| -4.3394% | |
| 7.5973% | |
| -4.2301% | |
| -6.8834% | |
| 63.7783% | |
| 47.2711% | |
| 33.147% | |
| 3,311.7317% | |
| 276.8618% | |
| 55.6514% | |
| 15.1546% | |
| -106.2673% | |
| -38.7908% | |
| -1.8478% | |
| 83.7049% | |
| 133.2435% | |
| 795.6212% | |
| 444.7504% | |
| 212.8848% | |
| 173.1118% | |
| 114.8303% | |
| 37.6809% | |
| -24.7697% | |
| -1,697.6195% | |
| -7,795.1001% | |
| -5,846.1584% | |
| -11,242.0886% | |
| 89.8977% | |
| 98.0332% | |
| 98.0271% | |
| 101.244% | |
| 1.3475% | |
| -25.949% | |
| -36.7951% | |
| -372.2023% | |
| -5,437.7729% | |
| -8,435.3759% | |
| -1,488.5615% | |
| -254.1798% | |
| -84.6441% | |
| -130.4599% | |
| -55.9514% | |
| 140.2353% | |
| 139.1744% | |
| 108.3284% | |
| 157.4702% | |
| -81.9959% | |
| -199.8481% | |
| -320.8338% | |
| -52.7531% | |
| 27.2033% | |
| -170.9456% | |
| 177.3211% | |
| 35.5025% | |
| 24.8718% | |
| 117.5358% | |
| 72.6562% | |
| 75.2997% | |
| 56.0555% | |
| -29.3672% | |
| -56.2116% | |
| -121.0656% | |
| -136.839% | |
| -247.1629% | |
| -227.968% | |
| -90.5043% | |
| -115.8315% |